000504 On Other Exchanges
Symbol
Exchange
Shenzhen

nanhua bio-medicine co ltd-a (000504) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NANHUA BIO-MEDICINE CO LTD-A (000504)
\

Related News

No related news articles were found.

nanhua bio-medicine co ltd-a (000504) Related Businessweek News

No Related Businessweek News Found

nanhua bio-medicine co ltd-a (000504) Details

NanHua Bio-medicine Co., Ltd. provides stem and immune cell storage, noninvasive genetic testing, and biological research and technical services. The company is based in Changsha, China.

365 Employees
Last Reported Date: 04/29/19

nanhua bio-medicine co ltd-a (000504) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nanhua bio-medicine co ltd-a
Nanhua Bio-Medicine Co., Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2018

NanHua Bio-medicine Co., Ltd. announced earnings results for the fourth quarter ended December 31, 2018. For the fourth quarter, the company announced For the full year, sales was CNY 95.381 million compared to CNY 67.392 million a year ago. Operating loss was CNY 34.658 million compared to CNY 35.814 million a year ago. Net loss was CNY 35.188 million compared to CNY 37.119 million a year ago. Basic loss per share from continuing operations was CNY 0.11 compared to CNY 0.12 a year ago. Sales was CNY 29.775 million compared to CNY 17.096 million a year ago. Operating loss was CNY 6.480 million compared to CNY 5.578 million a year ago. Net loss was CNY 6.546 million compared to CNY 7.265 million a year ago. Basic loss per share from continuing operations was CNY 0.02 compared to CNY 0.02 a year ago.

NanHua Bio-medicine Co., Ltd. to Report Fiscal Year 2018 Results on Apr 30, 2019

NanHua Bio-medicine Co., Ltd. announced that they will report fiscal year 2018 results on Apr 30, 2019

NanHua Bio-medicine Co., Ltd. to Report Q3, 2018 Results on Oct 31, 2018

NanHua Bio-medicine Co., Ltd. announced that they will report Q3, 2018 results on Oct 31, 2018

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

000504 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000504.
View Industry Companies
 

Industry Analysis

000504

Industry Average

Valuation 000504 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 39.7x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 34.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NANHUA BIO-MEDICINE CO LTD-A, please visit www.nhbiogroup.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.